NASDAQ: XFOR
X4 Pharmaceuticals Inc Stock Ownership - Who owns X4 Pharmaceuticals?

Insider buying vs selling

Have X4 Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adam R. CraigChair2026-08-1247,436$4.44
$210.81kSell
John VolponePres2026-08-1224,576$4.44
$109.22kSell
David KirskeChief Financial Officer2026-06-308,543$4.26
$36.43kSell
David KirskeChief Financial Officer2026-05-1216,961$4.29
$72.81kSell
Adam R. CraigExecutive Chairman2025-10-2386,206$2.90
$250.00kBuy

1 of 1

XFOR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XFOR insiders and whales buy or sell their stock.

XFOR Shareholders

What type of owners hold X4 Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paula Ragan3.37%3,337,386$10.05MInsider
Mary Dibiase1.15%1,140,980$3.43MInsider
Christophe Arbetengels0.87%864,207$2.60MInsider
Adam S. Mostafa0.86%850,000$2.56MInsider
Arthur Taveras0.39%388,026$1.17MInsider
Adam R. Craig0.33%328,651$989.24kInsider
John Volpone0.27%265,305$798.57kInsider
David Kirske0.17%167,750$504.93kInsider
Derek M. Meisner0.15%145,155$436.92kInsider
Diego Cadavid0.11%104,107$313.36kInsider

1 of 3

XFOR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XFOR0.10%7.96%Net SellingNet Selling
SABS0.08%56.99%Net Buying
IPSC0.09%23.43%Net SellingNet Selling
UPB0.09%33.20%Net SellingNet Selling
VNDA0.08%69.36%Net Selling

X4 Pharmaceuticals Stock Ownership FAQ

Who owns X4 Pharmaceuticals?

X4 Pharmaceuticals (NASDAQ: XFOR) is owned by 0.10% institutional shareholders, 7.96% X4 Pharmaceuticals insiders, and 91.94% retail investors. Paula Ragan is the largest individual X4 Pharmaceuticals shareholder, owning 3.34M shares representing 3.37% of the company. Paula Ragan's X4 Pharmaceuticals shares are currently valued at $10.05M.

If you're new to stock investing, here's how to buy X4 Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.